GoodRx (NASDAQ:GDRX) Price Target Lowered to $6.00 at KeyCorp

GoodRx (NASDAQ:GDRX – Get Free Report) had its price target cut by KeyCorp from $7.00 to $6.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. KeyCorp’s target price points to a potential upside of 39.53% from the company’s current price. Several other equities analysts have also […]

Leave a Reply

Your email address will not be published.

Previous post Farmers Trust Co. Increases Holdings in The Hershey Company (NYSE:HSY)
Next post Electric Mustang Mach-E Outsells Gasoline Mustang For The First Time in a Historic 2024 Shift